Item type | Current library | Shelving location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
BOOKs | National Law School | CIPRA Section | 346.048 COR-I (Browse shelf(Opens below)) | Not For Loan | 29907 |
Table of contents
Preface Carlos M. Correa;
HISTORY, INTERPRETATION AND PRINCIPLES;
1. Why IPR Issues Were Brought to GATT: A Historical Perspective on the Origins of TRIPS
Charles Clift;
2. Developing Countries in the Global IP System Before TRIPS: The Political Context for the TRIPS Negotiations
Carolyn Deere-Birkbeck;
3. Minimum Standards vs. Harmonization in the TRIPS Context: The Nature of Obligations under TRIPS and Modes of Implementation at the National Level in Monist and Dualist Systems
Denis Borges Barbosa ;
4. Enhancing Global Innovation Policy: The Role of WIPO and its Conventions in Interpreting the TRIPS Agreement
Graeme B. Dinwoodie and Rochelle C. Dreyfuss;
5. The Objectives and Principles of the TRIPS Agreement
Peter K. Yu;
6. Mainstreaming the TRIPS and Human Rights Interactions
Xavier Seuba;
7. The TRIPS Agreement and Intellectual Property Rights Exhaustion
Luis Mariano Genovesi;
8. Intellectual Property Rights and Competition Policy
Beatriz Conde Gallego ;
9. Intellectual Property Rights in Free Trade Agreements: Moving Beyond TRIPS Minimum Standards
Pedro Roffe, Christoph Spennemann and Johanna von Braun;
SUBSTANTIVE RIGHTS;
10. Limits, Limitations and Exceptions to Copyright under the TRIPS Agreement
P. Bernt Hugenholtz;
11. Copyright in TRIPS and Beyond: The WIPO Internet Treaties
Ruth L. Okediji;
12. The Protection of 'Related Rights' in TRIPS and the WIPO Performances and Phonograms Treaty
Owen Morgan;
13. Marks for Goods or Services (Trademarks)
Annette Kur;
14. Unresolved Issues on Geographical Indications in the WTO
Kasturi Das;
15. No 'Lemons' No More: A Sketch on the 'Economics' of Geographical Indications
Dwijen Rangnekar ;
16. Exploring the Flexibilities of TRIPS to Promote Biotechnology in Developing Countries
Graham Dutfield, Lois Muraguri and Florian Leverve;
17. Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options
Jerome H. Reichman;
18. The Doha Declaration and Access to Medicines by Countries Without Manufacturing Capacity
S.K. Verma;
19. Disease-based Limitations on Compulsory Licenses Under Articles 31 and 31bis
Kevin Outterson;
20. The Protection of Semiconductor Chip Products in TRIPS
Thomas Hoeren;
21. Data Exclusivity for Pharmaceuticals: TRIPS Standards and Industry's Demands in Free Trade Agreements
Carlos M. Correa;
Index
There are no comments on this title.